Jilin Haotai Health Industry Development Co., Ltd. participated in the 23rd World Pharmaceutical Raw Materials China Exhibition.
2025-06-24
"Leading with Innovation, Sailing towards Mutual Prosperity"
Haotai Health Advances into the Global Pharmaceutical Supply Chain
The 23rd World Pharmaceutical Raw Materials China Exhibition（CPHI China）
Time: June 24, 2025 - June 26, 2025
Location: Shanghai New International Expo Center（SNIEC）
Booth：E12B11
Organizer：Informa Markets、China Chamber of Commerce for Import and Export of Medicines and Health Products,
Shanghai Bohua International Exhibition Co., Ltd.
From June 24 to 26, 2025, CPHI & PMEC China (the 23rd World Pharmaceutical Raw Materials China Exhibition and the 18th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition) will be held at the Shanghai New International Expo Center.
In the critical period of China's new deep integration with the world, how to build a globally competitive pharmaceutical innovation ecosystem has become an important topic for the pharmaceutical industry. As a "business card" leading China's pharmaceutical industry to the world, CPHI & PMEC China work together, taking global perspective, professional depth and differentiated advantages as the cornerstone to help China's pharmaceutical industry open up a new pattern. With the theme of "Innovation-Driven Leadership, Integration for Win-Win", this year's CPHI China attracts over 3,500 domestic and foreign benchmark enterprises and more than 100,000 professional visitors from home and abroad. The exhibition area exceeds 230,000 square meters, building an efficient docking platform for the global pharmaceutical industry chain.
On the first day of the exhibition (June 24), Haotai Health focused on sharing biogenic pharmaceutical intermediate raw materials. In the fields of defibrotide sodium, pulmonary phospholipids, heparin, bilirubin, chondroitin sulfate, bovine liver extract, bovine prostate extract, etc., it interpreted the full-chain service network and demand solutions of "algorithmic R&D - gene synthesis - pilot scale-up - commercial production" for customers and visitors from Russia, India, South Korea, Iran, Egypt, the Netherlands, the UK, Germany, France, Belgium, Italy, Switzerland, Spain, and other regions. It also prepared rich industry cases, professional customized product solutions, and cutting-edge market insights.It has received a total of 27 well-known brand enterprises from foreign countries, China's Hong Kong and other regions, as well as more than 6,000 visitors.
Tomorrow (June 25), 5 intended customers from Belgium, Italy, Russia, India and Iran have made appointments for negotiations. We will focus on the sharing of high-value utilization products of Jilin Province's characteristic resources such as ginseng, Siberian hogfennel, corn silk and Asian wild onion, and continue to promote the full-chain innovation system of "technical development-resource transformation-green manufacturing-industry service" to intended customers and visitors around the world, so that Jilin's intelligent manufacturing can shine on the world stage.
Twelve scientists and technical talents from Haotai Health will also participate in 8 conferences and forums focusing on cutting-edge topics in vertical industries, covering diversified themes such as policy and regulation interpretation, life science instruments, advanced process technology innovation, cleanliness and environmental protection, market trend analysis, etc., contributing important driving force to the development of the pharmaceutical industry and technological innovation.
Haotai Health once again sincerely invites you to visit our booth (Booth No.: E12B11), have in-depth exchanges with our professional business team, share experiences and insights together, and discuss new opportunities in the pharmaceutical industry!
Related dynamics